1. Home
  2. ANAB vs KARO Comparison

ANAB vs KARO Comparison

Compare ANAB & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$53.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

KARO

Karooooo Ltd.

HOLD

Current Price

$63.49

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
KARO
Founded
2005
2001
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ANAB
KARO
Price
$53.61
$63.49
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
$71.67
$59.33
AVG Volume (30 Days)
818.3K
133.9K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
2.52%
EPS Growth
91.02
N/A
EPS
N/A
N/A
Revenue
$234,603,000.00
N/A
Revenue This Year
N/A
$22.17
Revenue Next Year
$52.14
$16.74
P/E Ratio
N/A
$24.13
Revenue Growth
157.01
N/A
52 Week Low
$17.11
$41.25
52 Week High
$73.30
$66.19

Technical Indicators

Market Signals
Indicator
ANAB
KARO
Relative Strength Index (RSI) 44.82 68.05
Support Level $52.32 $43.38
Resistance Level $57.70 $66.19
Average True Range (ATR) 4.55 2.87
MACD -0.98 0.17
Stochastic Oscillator 24.72 75.36

Price Performance

Historical Comparison
ANAB
KARO

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of an operational intelligence platform. Through its cloud platform, the company enables fleet and asset management, fuel management, workforce management, logistics, safety, including AI-assisted video safety, compliance, risk, and environmental impact management. Its segments are: Cartrack, which generates the majority of revenue, provides an operational intelligence platform that maximizes the value of transportation, operations, and workflow data through insightful real-time data analytics to connected vehicles and equipment, and Karooooo Logistics provides a software application enabling the management of last-mile B2B delivery and general operational logistics (Delivery-as-a-Service or DaaS). It generates the majority of its revenue from South Africa.

Share on Social Networks: